Northern Trust’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.8K | Hold |
59,571
| – | – | ﹤0.01% | 4285 |
|
|
2025
Q1 | $16.1K | Sell |
59,571
-24,711
| -29% | -$6.67K | ﹤0.01% | 4359 |
|
|
2024
Q4 | $43.8K | Buy |
84,282
+9,566
| +13% | +$4.97K | ﹤0.01% | 4278 |
|
|
2024
Q3 | $242K | Sell |
74,716
-4,259
| -5% | -$13.8K | ﹤0.01% | 3817 |
|
|
2024
Q2 | $237K | Sell |
78,975
-2,074
| -3% | -$6.22K | ﹤0.01% | 3806 |
|
|
2024
Q1 | $377K | Sell |
81,049
-15,218
| -16% | -$70.8K | ﹤0.01% | 3655 |
|
|
2023
Q4 | $399K | Buy |
96,267
+49,165
| +104% | +$204K | ﹤0.01% | 3619 |
|
|
2023
Q3 | $141K | Sell |
47,102
-348
| -0.7% | -$1.04K | ﹤0.01% | 3924 |
|
|
2023
Q2 | $117K | Sell |
47,450
-162,541
| -77% | -$400K | ﹤0.01% | 3995 |
|
|
2023
Q1 | $475K | Sell |
209,991
-18,358
| -8% | -$41.5K | ﹤0.01% | 3488 |
|
|
2022
Q4 | $797K | Sell |
228,349
-23,128
| -9% | -$80.7K | ﹤0.01% | 3345 |
|
|
2022
Q3 | $9.31M | Buy |
251,477
+1,406
| +0.6% | +$52.1K | ﹤0.01% | 2024 |
|
|
2022
Q2 | $4.75M | Buy |
250,071
+4,435
| +2% | +$84.2K | ﹤0.01% | 2552 |
|
|
2022
Q1 | $6.63M | Buy |
245,636
+71,704
| +41% | +$1.94M | ﹤0.01% | 2405 |
|
|
2021
Q4 | $3.92M | Buy |
173,932
+10,727
| +7% | +$242K | ﹤0.01% | 2838 |
|
|
2021
Q3 | $4.28M | Buy |
163,205
+6,807
| +4% | +$178K | ﹤0.01% | 2828 |
|
|
2021
Q2 | $5.01M | Sell |
156,398
-6,296
| -4% | -$202K | ﹤0.01% | 2837 |
|
|
2021
Q1 | $5.73M | Sell |
162,694
-10,274
| -6% | -$362K | ﹤0.01% | 2669 |
|
|
2020
Q4 | $5.55M | Sell |
172,968
-4,050
| -2% | -$130K | ﹤0.01% | 2626 |
|
|
2020
Q3 | $6.66M | Sell |
177,018
-5,305
| -3% | -$200K | ﹤0.01% | 2357 |
|
|
2020
Q2 | $8.16M | Buy |
182,323
+155,710
| +585% | +$6.97M | ﹤0.01% | 2224 |
|
|
2020
Q1 | $908K | Buy |
26,613
+2,332
| +10% | +$79.6K | ﹤0.01% | 3254 |
|
|
2019
Q4 | $947K | Buy |
+24,281
| New | +$947K | ﹤0.01% | 3417 |
|